Lumiradx announces strategic refocus and cost restructuring program

London, april 06, 2023 (globe newswire) -- lumiradx limited (nasdaq: lmdx), a leading global provider of point-of-care diagnostics testing solutions, today announced its strategic refocus and cost restructuring program aimed at reducing its scale and operations to pre-pandemic levels and to further evolve lumiradx into an agile organization with a clear focus on the areas with the greatest potential.
LMDX Ratings Summary
LMDX Quant Ranking